IL2 Imaging in Renal Transplantation
A Proof of Concept Study for [18F]FB-IL2 PET Imaging of Infiltrating T Cells After Renal Transplantation; a Diagnostic Tool for Acute Rejection
Sponsor: University Medical Center Groningen
Listed as NCT03304223, this NA trial focuses on Kidney Transplant Rejection and remains ongoing. Sponsored by University Medical Center Groningen, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting · Phase: PHASE1 → NA
-
Mar 2022 — Jun 2023 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE1
-
Feb 2019 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE1
-
Oct 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .